NCT06520618View on ClinicalTrials.gov

Clinical Study on the Efficacy and Safety of Qingre Heji in the Treatment of Acute Upper Respiratory Tract Infection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions
Acute Upper Respiratory Tract InfectionTraditional Chinese MedicineRandomised Controlled Trial
Interventions
DRUG

Qing Re He Ji

Oral administration of Qing Re He Ji

DRUG

Shuanghuanglian Oral Liquid

Oral administration of Shuanghuanglian Oral Liquid

Trial Locations (1)

110000

Shengjing Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

Shengjing Hospital

OTHER